New Owner
Allergan - Motus Therapeutics
Allergan acquires Motus Therapeutics
Announced: October 27, 2016
Type: Acquisition
Disposition: Subsidiary
Status: Complete
Amount: $ 200,000,000
Allergan Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Feb 13, 2017 |
|
$ 2,470,000,000 |
| Jan 09, 2017 |
|
Undisclosed amount |
| Dec 20, 2016 |
|
$ 2,900,000,000 |
| Nov 22, 2016 |
|
$ 125,000,000 |
| Sep 20, 2016 |
|
Undisclosed amount |
